F.D.A. chief goes against the administration stereotype

New York Times

11 February 2018 - Dr. Scott Gottlieb isn’t rolling back his agency’s mission, although he is straddling the interests of the drug and health industries along with public health.

Scott Gottlieb, the commissioner of the FDA, came to the job with a résumé straight out of the Trump administration’s playbook.

A millionaire with a libertarian bent, he made his money working for the industry he now regulates, and had investments in 20 health care companies whose products could come before the agency for approval. Pharmaceutical and medical device executives enthusiastically supported his nomination, while consumer and public health groups sounded the requisite alarms.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Management